Image

Evaluation of Desensitization Therapy and Re-treatment of Eye Movement Information [EMDR] in Patients With Post-traumatic Stress Disorder [PTSD]

Evaluation of Desensitization Therapy and Re-treatment of Eye Movement Information [EMDR] in Patients With Post-traumatic Stress Disorder [PTSD]

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This research aims to confirm that the therapeutic effect of EMDR is associated with changes in the interaction between cognitive function and emotional stimuli in PTSD patients compared to a controlled therapy in a randomized, single-blind study.On the other hand, this study aims to observe neuronal and cognitive correlates related to EMDR therapy compared to a control therapy.

This investigation would improve the understanding of the mechanisms of action of the EMDR, still unknown to date.

Eligibility

Inclusion Criteria:

  • Patient diagnosed with PTSD according to DSM 5 criteria (APA 2013) related to a single traumatic event,
  • Aged 18 to 65 years,
  • Signed informed consent.
  • Patient with social security affiliation or State Medical Aid (AME)

Exclusion Criteria:

  • Neurological disorders
  • No other major psychiatric disorders than PTSD (DSM 5)
  • Severe and/or unstable somatic pathologies,
  • Patient not affiliated with social security,
  • Patient hospitalized under stress in psychiatric care at the decision of the state representative or in psychiatric care at the request of a third party,
  • Patient under guardianship,
  • Patient participating in parallel with other biomedical research,
  • Change of antidepressant during the last three months,
  • Patient not fluent in French
  • MR-specific criteria for not inclusion:
  • women of childbearing age without effective contraception or a positive pregnancy test,
  • patients carrying pacemakers or electrical or electronic devices, clips or metal prostheses,
  • subjects with neurological disorders, cerebral abnormalities or suffering from claustrophobia.

Study details
    Post-traumatic Stress Disorder

NCT04431765

Centre hospitalier de Ville-Evrard, France

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.